ALMANA (08186): Lisa has been appointed as an executive director.
Man Mei (08186) announced that as of April 13, 2026, Ms. Lisa has been appointed as an executive director; Mr. Shen Leyuan has been appointed as an independent non-executive director and a member of the Audit Committee, Nomination Committee, and Remuneration Committee; Ms. Peng Jingsi has resigned as an independent non-executive director of the company and no longer serves as the chairman and member of the Audit Committee, Nomination Committee, and Remuneration Committee; and Mr. Han Mingsheng has been appointed as the chairman of the Audit Committee, Nomination Committee, and Remuneration Committee.
ALMANA (08186) announced that as of April 13, 2026, Ms. Lisa has been appointed as an executive director; Mr. Shen Leyuan has been appointed as an independent non-executive director and a member of the audit committee, nomination committee, and remuneration committee; Ms. Peng Jingsi has resigned as an independent non-executive director of the Company and will no longer serve as the chairperson and member of the audit committee, nomination committee, and remuneration committee; and Mr. Han Mingsheng has been appointed as the chairman of the audit committee, nomination committee, and remuneration committee.
Related Articles
CSSC Offshore & Marine Engineering (00317) announced a 95.16% to 133.11% year-on-year increase in its expected first-quarter net profit attributable to shareholders to approximately RMB 360 million to RMB 430 million.
CHINA CHENGTONG (00217) subsidiary enters into a sale-leaseback agreement with Huadian Datong New Energy.
Fosun Pharma Industrial Pte.Ltd. increases its stake in SISRAM MED (01696) by approximately 335 million shares at a price of HK$3.34 per share.
CSSC Offshore & Marine Engineering (00317) announced a 95.16% to 133.11% year-on-year increase in its expected first-quarter net profit attributable to shareholders to approximately RMB 360 million to RMB 430 million.
CHINA CHENGTONG (00217) subsidiary enters into a sale-leaseback agreement with Huadian Datong New Energy.
Fosun Pharma Industrial Pte.Ltd. increases its stake in SISRAM MED (01696) by approximately 335 million shares at a price of HK$3.34 per share.
RECOMMEND
